Biopsychosocial Assessments for Pubertal Suppression to Treat Adolescent Gender Dysphoria.
| Autor: | Turban JL; University of California, San Francisco. Electronic address: jack.turban@ucsf.edu., Thornton J; University of California, San Francisco., Ehrensaft D; University of California, San Francisco. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2024 Apr 04. Date of Electronic Publication: 2024 Apr 04. |
| DOI: | 10.1016/j.jaac.2024.03.016 |
| Abstrakt: | Transgender and gender diverse (TGD) adolescents are those whose gender identity is incongruent with societal expectations based on their sex assigned at birth. 1 Some TGD adolescents may meet criteria for gender dysphoria, which requires at least 6 months of psychological distress related to gender incongruence. 1 Such adolescents may seek pubertal suppression with a gonadotropin-releasing hormone agonist (GnRHa). 1 GnRHa temporarily and reversibly suppress endogenous puberty, allowing adolescents to engage with care without puberty-related psychological distress. 2 Most patients treated with GnRHa proceed to treatment with gender-affirming hormones (eg, estrogen or testosterone to induce puberty that aligns with their gender identity), whereas a small number choose to stop GnRHa treatment, allowing endogenous puberty to proceed. 2 Longitudinal cohort and cross-sectional studies link GnRHa treatment to improved mental health outcomes, when provided in accordance with clinical guidelines. 2 . (Copyright © 2024 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|